Showing results (511-520 of 523) with videos related to

Sort By:
Pageof 53
International Journal of Dermatology|May 18, 2026
Position Statement of the EADV Task Forces With External Experts on Quality of Life Measurement in Hidradenitis Suppurativa: An UpdatePavel V Chernyshov, Gregor Jemec, Andrew Finlay, et al.
JAMA Network Open|February 16, 2024
Health Economic Consequences Associated With COVID-19-Related Delay in Melanoma Diagnosis in EuropeLara V Maul, Dagmar Jamiolkowski, Rebecca A Lapides, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|July 24, 2023
Itch, sleep loss, depressive symptoms, fatigue, and productivity loss in patients with moderate-to-severe atopic dermatitis: Analyses of TREATgermany registry dataThomas Birkner, Doreen Siegels, Luise Heinrich, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 30, 2026
Patient treatment needs in atopic dermatitis: A real-world cohort studyKristina Ludemann, Stephan Traidl, Angela Cornelius, et al.
The British Journal of Dermatology|July 27, 2022
Real-world data on the effectiveness, safety and drug survival of dupilumab: an analysis from the TREATgermany registryDora Stölzl, Nicole Sander, Annice Heratizadeh, et al.
Acta Dermato-Venereologica|January 23, 2023
Itching in Atopic Dermatitis: Patient- and Physician-reported Outcomes in the German Atopic Dermatitis Registry TREATgermanyElke Weisshaar, Philipp Bentz, Christian Apfelbacher, et al.
JAMA Dermatology|May 1, 2024
International Consensus Definition and Diagnostic Criteria for Generalized Pustular Psoriasis From the International Psoriasis CouncilSiew Eng Choon, Peter van de Kerkhof, Johann E Gudjonsson, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 24, 2026
Delphi consensus: First-line use of biologics and small molecules in hidradenitis suppurativaGeorgios Nikolakis, Erkan Alpsoy, Florian Anzengruber, et al.
Pageof 53